Da An Gene Co Ltd of Sun Yat-Sen University

Daan Gene's wholly-owned subsidiary, Guangzhou Datai Bioengineering Technology Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration for its Alpha-Fetoprotein Assay Kit (Chemiluminescence Method). The certificate is valid until August 3, 2031. The product is used for the in vitro quantitative determination of alpha-fetoprotein levels in human serum and plasma, primarily for treatment monitoring of primary liver cancer. The product is currently still in the market development stage.

Daan Gene has obtained a medical device registration certificate from the National Medical Products Administration for its Hepatitis B Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), valid until July 15, 2031. The kit is used for in vitro quantitative detection of hepatitis B virus deoxyribonucleic acid content in human serum or plasma samples. The acquisition of this registration certificate enriches the company's product portfolio and broadens the application areas of its products. In the first quarter of 2026, Daan Gene achieved revenue of 149 million yuan and a net loss attributable to the parent company of 98.15 million yuan.

Guangdong state-owned enterprises are intensifying acquisitions of a batch of new quality productive forces targets, exploring the path of empowering restructurings. Guangzhou Light Industry Group successively acquired Taimushi and Cangzhou Mingzhu in 2025, with the controlling stake transaction for Cangzhou Mingzhu totaling approximately 710 million yuan, and completed the delivery in March this year, subsequently promoting the establishment of its South China base in Zengcheng, Guangzhou. Guangzhou Industrial Investment Holdings Group took a controlling stake in Xusheng Group, a leader in automotive precision aluminum alloy components, for about 4.295 billion yuan in April this year, having previously acquired Tianhai Electronics and Farasis Energy, forming an automotive parts industry cluster exceeding 50 billion yuan. Shenzhen state-owned Shahé Corporation completed the acquisition of a 70 percent stake in Jinghua Electronics, becoming the first cross-border merger under Shenzhen's new restructuring policy. Zhuhai state-owned assets transferred a 16.67 percent stake in Sunsea AIoT to Sci-Tech Haike at no cost. Zhongshan Public Utilities acquired new energy assets within the system for 408 million yuan. Lingnan Holdings plans to acquire an 85 percent stake in Guangzhou Digital Group's Guangzhou Broadcasting City Services. Guangzhou Pharmaceutical Holdings is advancing the acquisition of Daan Gene to connect the pharmaceutical and testing industry chain. Industry insiders point out that this round of state-owned enterprise mergers and acquisitions places greater emphasis on obtaining controlling stakes and actual operational leadership, aiming to achieve two-way empowerment of resource integration and regional development.